Annika Muskantor

Annika Muskantor

Plus aucun poste en cours
60 ans
Health Technology
Consumer Services
Technology Services

Profil

Annika Muskantor served as the Chief Financial Officer at Oncopeptides AB from 2021 to 2023.
Prior to that, she worked as the Interim Chief Financial Officer at Dun & Bradstreet AB. In 2012 to 2013, she held the position of Chief Financial Officer at Swedish Orphan Biovitrum AB. From 2019 to 2021, she served as the Chief Financial Officer at FRISQ Holding AB. Ms. Muskantor also worked as an Interim Chief Financial Officer at Zodiak Media AB, eBay Sweden Services AB, and Scienta Omicron AB. She was the Chief Financial Officer at Ganni A. Currently, she is the Chief Financial Officer at Net Insight AB. Ms. Muskantor completed her undergraduate studies at Northwestern University and holds an MBA from Kellogg School of Management.

Anciens postes connus de Annika Muskantor

SociétésPosteFin
NET INSIGHT AB Directeur Financier/CFO 14/08/2024
ONCOPEPTIDES AB Directeur Financier/CFO 18/01/2023
Directeur Financier/CFO 31/03/2021
SWEDISH ORPHAN BIOVITRUM AB Directeur Financier/CFO 08/04/2013
Directeur Financier/CFO -
Voir l'expérience en détail de Annika Muskantor

Formation de Annika Muskantor

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

22

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Electronic Technology

Consumer Services

Health Technology

Technology Services

Health Technology

Consumer Non-Durables

Consumer Services

Technology Services

Consumer Services

Technology Services

Health Technology

  1. Bourse
  2. Insiders
  3. Annika Muskantor